GELAIN, ARIANNA
GELAIN, ARIANNA
Dipartimento di Scienze Farmaceutiche
Eco-Friendly Bio-Based Solvents for the Acetylation of the Amino Group of Amino Acids
2024 G. Cazzaniga, A. Tresoldi, A. Gelain, F. Meneghetti, M. Mori, S. Villa
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus
2024 M. Mori, M. Cocorullo, A. Tresoldi, G. Cazzaniga, A. Gelain, G. Stelitano, L.R. Chiarelli, M. Tomaiuolo, P. Delre, G.F. Mangiatordi, M. Garofalo, A. Cassetta, S. Covaceuszach, S. Villa, F. Meneghetti
Ironing out Fe3+ acquisition in M. abscessus: a new strategy to target virulence factors in non-tuberculous mycobacteria
2023 M. Mori, A. Tresoldi, G. Cazzaniga, A. Gelain, G. Stelitano, M. Cocorullo, L.R. Chiarelli, P. Delre, G.F. Mangiatordi, A. Cassetta, S. Covaceuszach, S. Villa, F. Meneghetti
Discovery of novel SIRT5 activators as potential anti-inflammatory agents
2023 A. Gelain, . Mori, G. Cazzaniga, F. Meneghetti, . Wong, L. Jun Yan, P.S. Coghi, S. Villa
Optimizing the drug discovery process for the development of MbtI inhibitors as promising anti-virulence agents against TB
2023 M. Mori, G. Cazzaniga, A. Tresoldi, A. Gelain, L.R. Chiarelli, G. Stelitano, M. Bellinzoni, S. Villa, F. Meneghetti
Natural and nature-inspired compounds targeting E. coli WrbA as antibiofilm agents: computational studies, synthesis, and biological evaluation
2023 M. Mori, S. Villa, A. Ratti, F. Meneghetti, G. Roda, A. Gelain, F. Villa, E.M.A. Fassi, F. Forlani, G. Grazioso
Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria
2023 M. Mori, G. Stelitano, G. Cazzaniga, A. Gelain, A. Tresoldi, M. Cocorullo, M. Roversi, L.R. Chiarelli, M. Tomaiuolo, P. Delre, G. Felice Mangiatordi, A. Griego, L. Rizzello, A. Cassetta, S. Covaceuszach, S. Villa, F. Meneghetti
Targeting the mycobactin biosynthesis pathway in M. tuberculosis: a step towards the improvement of the anti-virulence activity of MbtI inhibitors
2022 M. Mori, S. Villa, L.R. Chiarelli, G. Stelitano, A. Gelain, G. Cazzaniga, M. Bellinzoni, L. Rizzello, E. Scarpa, A. Griego, A. Fumagalli, F. Meneghetti
Development of a novel approach to overcome biofilm formation by natural product derivatives
2022 A. Gelain, G. Cazzaniga, M. Mori, P.J. Molino, P. Hajes, F. Villa, C. Cattò, F. Cappitelli, S. Villa
Natural compounds targeting E. Coli WRBA as antibiofilm agents: Virtual screening, design and synthesis of analogs, biological evaluation
2022 S. Villa, M. Mori, I.A. Ratt, F. Meneghetti, G. Roda, A. Gelain, F. Villa, E. Fassi, F. Forlani, G. Grazioso
New strategies to overcome biofilm formation by natural product derivatives
2022 S. Villa, G. Cazzaniga, M. Mori, P.J. Molino, P. Hayes, F. Villa, C. Cattò, F. Cappitelli, A. Gelain
Insights on the Modulation of SIRT5 Activity: A Challenging Balance
2022 M. Mori, G. Cazzaniga, F. Meneghetti, S. Villa, A. Gelain
Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections
2022 M. Mori, G. Stelitano, A. Griego, L.R. Chiarelli, G. Cazzaniga, A. Gelain, E. Pini, M. Camera, P. Canzano, A. Fumagalli, E. Scarpa, C. Cordiglieri, L. Rizzello, S. Villa, F. Meneghetti
Functionalized nanoparticles as potential antibiofilm agents
2021 A. Gelain, M. Mori, F. Meneghetti, P. Molino, P. Hayes, S. Villa
New Nanoparticles Endowed with Antibiofilm Activity
2021 A. Gelain, P. Molino, P. Hayes, S. Villa
Structural insights into the inhibition of M. tuberculosis salicylate synthase (MbtI)
2021 M. Mori, S. Villa, L.R. Chiarelli, G. Stelitano, A. Gelain, T. Tuccinardi, M. Bellinzoni, F. Meneghetti
Benzothiadiazole derivatives endowed with STAT3 inhibition
2021 A. Gelain, M. Mori, E. Gilardoni, L. Regazzoni, A. Pedretti, D. Colombo, G. Parkinson, A. Asai, F. Meneghetti, S. Villa
Natural products against key Mycobacterium tuberculosis enzymatic targets : Emerging opportunities for drug discovery
2021 G. Cazzaniga, M. Mori, L. Roberto Chiarelli, A. Gelain, F. Meneghetti, S. Villa
Unraveling the interaction mechanism of a benzothiadiazole-2.2-dioxide derivative with STAT3 : towards novel direct inhibitors
2021 M. Mori, E. Gilardoni, L. Regazzoni, A. Pedretti, D. Colombo, G. Parkinson, A. Asai, G. Cazzaniga, F. Meneghetti, S. Villa, A. Gelain
Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents
2021 M. Mori, G. Stelitano, L.R. Chiarelli, G. Cazzaniga, A. Gelain, D. Barlocco, E.R.E. Pini, F. Meneghetti, S. Villa